Patents by Inventor Robert A. Ganz

Robert A. Ganz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10835504
    Abstract: The present disclosure relates to topical compositions comprising one or more topical anesthetics or analgesics; a vitamin B3 compound; and a coating agent. In some embodiments, the composition comprises about 1% to about 10% w/w of the composition of the topical anesthetic, topical analgesic, or a combination thereof; about 1% to about 10% w/w of the composition of the vitamin B3 compound; and about 5% to about 50% w/w of the composition of the coating agent. In some embodiments, the composition further includes a pharmaceutically acceptable base. In some embodiments, the pharmaceutically acceptable base comprises about 35% to about 85% w/w of the composition of a pharmaceutically acceptable oil; about 1% to about 20% w/w of the composition of a pharmaceutically acceptable wax; or a combination thereof. Such compositions are useful for treating anal itch or pruritus ani.
    Type: Grant
    Filed: April 18, 2019
    Date of Patent: November 17, 2020
    Assignee: G&S Laboratories, Inc.
    Inventors: Robert A. Ganz, Mo E. Saremi, William Christopfel
  • Publication number: 20200297386
    Abstract: A method can include introducing a device into a lung of a patient to a site of a material lodged in the lung. The device can include a distal end configured to core the material, a proximal end, and a tube that includes a hollow interior. The method can further include coring from the material a piece that is sized to pass through the hollow interior of the tube using the distal end of the device. The method can further include applying suction to the proximal end of the device to pass the piece through the hollow interior of the tube and out of the device through the proximal end. Other and further methods are also disclosed.
    Type: Application
    Filed: June 12, 2020
    Publication date: September 24, 2020
    Applicant: Piranha Medical, LLC
    Inventors: Robert A. Ganz, Mark Anders Rydell
  • Patent number: 10722267
    Abstract: A device is configured to clear a bolus of food impacted within an esophagus, the device including a catheter tube having a hollow interior and a distal end configured to core the bolus of food and a proximal end configured to be coupled to a source of suction to clear the core.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: July 28, 2020
    Assignee: Piranha Medical, LLC
    Inventors: Robert A. Ganz, Mark Anders Rydell
  • Publication number: 20200170818
    Abstract: Various devices, systems, and methods that can be used in the treatment of obesity and related illnesses are disclosed. In some instances, a portion of the bowel of an obese patient is distended for a therapeutically effective period. The distention may be achieved by introduction of an object that is of foreign origin relative to the body of the patient into the bowel of the patient. In some instances, the distention is achieved by a medical device that transitions from an undeployed state, in which the medical device is introduced into the bowel of the patient, to an expanded state in which the medical device distends the bowel by an amount sufficient to trigger an intestinal-gastric brake in the patient.
    Type: Application
    Filed: February 7, 2020
    Publication date: June 4, 2020
    Applicant: Ganz Brake, LLC
    Inventors: Alexander S. Ganz, Robert A. Ganz
  • Publication number: 20200138077
    Abstract: The present disclosure relates to compositions comprising dietary fibers. For example, in some embodiments, the composition comprises two or more fibers (e.g., fibers such as wheat dextrin, inulin, pectin, or potato starch) each present in amount of about 2% to about 6% w/w of the composition. The present disclosure also relates to partially hydrolyzed dietary fibers and methods to prepare a partially hydrolyzed dietary. In some embodiments, the composition comprises further comprises an acid and/or a preservative present in an amount of about 0.01% to about 2% w/w of the composition. In some embodiments, the composition further includes a sweetener and/or a flavoring agent. Such compositions are useful in the treatment or improvement of gastrointestinal diseases.
    Type: Application
    Filed: October 31, 2019
    Publication date: May 7, 2020
    Inventors: Robert A. Ganz, Mo E. Saremi, William Christopfel
  • Patent number: 10596021
    Abstract: Various devices, systems, and methods that can be used in the treatment of obesity and related illnesses are disclosed. In some instances, a portion of the bowel of an obese patient is distended for a therapeutically effective period. The distention may be achieved by introduction of an object that is of foreign origin relative to the body of the patient into the bowel of the patient. In some instances, the distention is achieved by a medical device that transitions from an undeployed state, in which the medical device is introduced into the bowel of the patient, to an expanded state in which the medical device distends the bowel by an amount sufficient to trigger an intestinal-gastric brake in the patient.
    Type: Grant
    Filed: December 23, 2017
    Date of Patent: March 24, 2020
    Assignee: Ganz Brake, LLC
    Inventors: Alexander S. Ganz, Robert A. Ganz
  • Publication number: 20190321427
    Abstract: The present disclosure relates to topical compositions comprising a dermo-muscle relaxant, and optionally, one or more topical anesthetics or analgesics; a vitamin B3 compound; and/or a pharmaceutically acceptable plant extract. In some embodiments, the composition includes about 10% to about 20% w/w of the composition of the dermo-muscle relaxant. In some embodiments, the composition further includes about 1% to about 10% w/w of the composition of the topical anesthetic, topical analgesic, or a combination thereof. In some embodiments, the composition further includes a pharmaceutically acceptable base. In some embodiments, the pharmaceutically acceptable base comprises about 35% to about 95% w/w of the composition of a pharmaceutically acceptable oil, about 5% to about 25% w/w of the composition of a pharmaceutically acceptable wax, or a combination thereof. Such compositions are useful for treating anal fissure and cuts, abrasions, injuries, burns, and/or breakages on the skin.
    Type: Application
    Filed: April 18, 2019
    Publication date: October 24, 2019
    Inventors: Robert A. Ganz, Mo E. Saremi, William Christopfel
  • Publication number: 20190321312
    Abstract: The present disclosure relates to topical compositions comprising one or more topical anesthetics or analgesics; a vitamin B3 compound; and a coating agent. In some embodiments, the composition comprises about 1% to about 10% w/w of the composition of the topical anesthetic, topical analgesic, or a combination thereof; about 1% to about 10% w/w of the composition of the vitamin B3 compound; and about 5% to about 50% w/w of the composition of the coating agent. In some embodiments, the composition further includes a pharmaceutically acceptable base. In some embodiments, the pharmaceutically acceptable base comprises about 35% to about 85% w/w of the composition of a pharmaceutically acceptable oil; about 1% to about 20% w/w of the composition of a pharmaceutically acceptable wax; or a combination thereof. Such compositions are useful for treating anal itch or pruritus ani.
    Type: Application
    Filed: April 18, 2019
    Publication date: October 24, 2019
    Inventors: Robert A. Ganz, Mo E. Saremi, William Christopfel
  • Publication number: 20190314181
    Abstract: Various devices, systems, and methods that can be used in the treatment of obesity and related illnesses are disclosed. In some instances, the cecum of an obese patient is distended to a pathophysiological size for a therapeutically effective period. The distention may be achieved by introduction of an object that is of foreign origin relative to the body of the patient into the cecum of the patient. In some instances, the distention is achieved by a medical device that transitions from an undeployed state, in which the medical device is introduced into the cecum of the patient, to an expanded state in which the medical device distends the cecum by an amount sufficient to trigger a colo-gastric brake in the patient.
    Type: Application
    Filed: June 27, 2019
    Publication date: October 17, 2019
    Applicant: Emerald Ridge Medical, LLC
    Inventors: Alexander S. Ganz, Robert A. Ganz, Travis Sessions, Steven Berhow, Michael W. Augustine
  • Publication number: 20190313774
    Abstract: A method and apparatus for attaching tissue to bone in a shifted position without requiring surgical detachment of muscle or connective tissue joining the tissue layer to the bone layer. The skin layer is gently pulled in a non-surgical manner and a fastener of the invention is driven through the skin layer into the bone layer to effect a “skin tightening” procedure.
    Type: Application
    Filed: June 26, 2019
    Publication date: October 17, 2019
    Applicant: Zift Medical, LLC
    Inventors: Robert S. Schwartz, Stanton J. Rowe, Robert A. Van Tassel, Ralph Schneider, Ming Wu, David John Blaeser, Philip Jon Haarstad, Eric J. Simso, Douglas Jay Krone, Brian Zelickson, Robert A. Ganz, Matt Blaeser, Matt Keillor
  • Publication number: 20190201183
    Abstract: A method and apparatus for attaching tissue to bone in a shifted position without requiring surgical detachment of muscle or connective tissue joining the tissue layer to the bone layer. The skin and/or soft tissue layer is displaced in a surgical or non-surgical manner and a fastener of the invention is driven through the skin and/or soft tissue layer into the periosteum or bone layer to affect a tissue repositioning procedure. The method and apparatus may also be used to attach tissue to tissue an a shifted position.
    Type: Application
    Filed: December 29, 2017
    Publication date: July 4, 2019
    Applicant: Zift, LLC
    Inventors: Robert S. Schwartz, Stanton J. Rowe, Robert A. Van Tassel, Ralph Schneider, Ming Wu, David John Blaeser, Eric J. Simso, Philip Jon Haarstad, Douglas Jay Krone, Brian Zelickson, Robert A. Ganz, Matt Blaeser, Matt Keillor
  • Publication number: 20180344993
    Abstract: A system for clearing a blockage from a lumen of a patient, such as an impacted food bolus, can include a catheter that includes a distal end for insertion into the lumen of the patient. The catheter further includes a proximal end for coupling with a suction source at a position external to the patient. The catheter further includes a lumen extending through the proximal and distal ends. The system can include a cutting tip for cutting a morsel from the bolus as suction is applied to the bolus via the lumen of the catheter. The system can also include a positioning element that transitions from an undeployed state to a deployed state, which is expanded relative to the undeployed state. The positioning element can contact the esophagus to space the cutting tip from the esophagus when in the deployed state.
    Type: Application
    Filed: May 31, 2018
    Publication date: December 6, 2018
    Inventors: Robert A. Ganz, Mark Anders Rydell, Travis Sessions, Steven Berhow, Doug Wahnschaffe, Michael W. Augustine
  • Publication number: 20180280040
    Abstract: A system for clearing a blockage in a patient can include a tubular member that defines a channel, the tubular member being insertable into an esophagus of the patient. The system can further include a catheter assembly that includes a catheter tube, which defines a length greater than a length of the tubular member and is passable through the channel of the tubular member while the tubular member is positioned in the esophagus of the patient. The catheter tube can include a distal tip that defines a cutting element to core the blockage positioned in the esophagus of the patient. The catheter assembly can further include a proximal end coupled with the catheter tube, the proximal end being couplable with a vacuum line such that, when suction is provided via the vacuum line, advancement of the catheter tube into contact with the blockage cores from the blockage a piece of the blockage that is passed through the catheter.
    Type: Application
    Filed: May 31, 2018
    Publication date: October 4, 2018
    Inventors: Robert A. Ganz, Mark Anders Rydell, Travis Sessions, Steven Berhow, Doug Wahnschaffe, Michael W. Augustine
  • Publication number: 20180177623
    Abstract: Various devices, systems, and methods that can be used in the treatment of obesity and related illnesses are disclosed. In some instances, a portion of the bowel of an obese patient is distended for a therapeutically effective period. The distention may be achieved by introduction of an object that is of foreign origin relative to the body of the patient into the bowel of the patient. In some instances, the distention is achieved by a medical device that transitions from an undeployed state, in which the medical device is introduced into the bowel of the patient, to an expanded state in which the medical device distends the bowel by an amount sufficient to trigger an intestinal-gastric brake in the patient.
    Type: Application
    Filed: December 23, 2017
    Publication date: June 28, 2018
    Inventors: Alexander S. Ganz, Robert A. Ganz
  • Patent number: 9993281
    Abstract: Devices and methods for ablating tissue in the wall of various organs of the gastrointestinal tract of a patient in order to cure or ameliorate metabolic pathophysiological conditions such as obesity, insulin resistance, or type 2 diabetes mellitus are provided. Ablational treatment of target areas may be fractional or partial, rendering a post-treatment portion of target tissue ablated and another portion that is substantially intact. Fractional ablation is achieved by controlling the delivery of ablational energy across the surface area being treated, and controlling the depth of energy penetration into tissue. Surface area control of energy delivery may controlled by the spatial pattern of distributed ablation elements or by the selective activation of a subset of a dense pattern of ablation elements. Embodiments of the device include an ablational electrode array that spans 360 degrees and an array that spans an arc of less than 360 degrees.
    Type: Grant
    Filed: November 26, 2013
    Date of Patent: June 12, 2018
    Assignee: Covidien LP
    Inventors: Douglas Kelly, David S. Utley, Robert A. Ganz, Michael P. Wallace, Nathan Every
  • Publication number: 20170150993
    Abstract: A device is configured to clear a bolus of food impacted within an esophagus, the device including a catheter tube having a hollow interior and a distal end configured to core the bolus of food and a proximal end configured to be coupled to a source of suction to clear the core.
    Type: Application
    Filed: November 21, 2016
    Publication date: June 1, 2017
    Inventors: Robert A. Ganz, Mark Anders Rydell
  • Publication number: 20160206081
    Abstract: A method and apparatus for attaching tissue to bone in a shifted position without requiring surgical detachment of muscle or connective tissue joining the tissue layer to the bone layer. The skin layer is gently pulled in a non-surgical manner and a fastener of the invention is driven through the skin layer into the bone layer to effect a “skin tightening” procedure.
    Type: Application
    Filed: November 13, 2015
    Publication date: July 21, 2016
    Applicant: ZIFT MEDICAL, LLC
    Inventors: Robert S. Schwartz, Stanton J. Rowe, Robert A. Van Tassel, Ralph Schneider, Ming Wu, David John Blaeser, Philip Jon Haarstad, Eric J. Simso, Douglas Jay Krone, Brian Zelickson, Robert A. Ganz
  • Publication number: 20140088581
    Abstract: Devices and methods for ablating tissue in the wall of various organs of the gastrointestinal tract of a patient in order to cure or ameliorate metabolic pathophysiological conditions such as obesity, insulin resistance, or type 2 diabetes mellitus are provided. Ablational treatment of target areas may be fractional or partial, rendering a post-treatment portion of target tissue ablated and another portion that is substantially intact. Fractional ablation is achieved by controlling the delivery of ablational energy across the surface area being treated, and controlling the depth of energy penetration into tissue. Surface area control of energy delivery may controlled by the spatial pattern of distributed ablation elements or by the selective activation of a subset of a dense pattern of ablation elements. Embodiments of the device include an ablational electrode array that spans 360 degrees and an array that spans an arc of less than 360 degrees.
    Type: Application
    Filed: November 26, 2013
    Publication date: March 27, 2014
    Applicant: Covidien LP
    Inventors: DOUGLAS KELLY, DAVID S. UTLEY, ROBERT A. GANZ, MICHAEL P. WALLACE, NATHAN EVERY
  • Patent number: 8641711
    Abstract: Devices and methods for ablating tissue in the wall of various organs of the gastrointestinal tract of a patient in order to cure or ameliorate metabolic pathophysiological conditions such as obesity, insulin resistance, or type 2 diabetes mellitus are provided. Ablational treatment of target areas may be fractional or partial, rendering a post-treatment portion of target tissue ablated and another portion that is substantially intact. Fractional ablation is achieved by controlling the delivery of ablational energy across the surface area being treated, and controlling the depth of energy penetration into tissue. Surface area control of energy delivery may controlled by the spatial pattern of distributed ablation elements or by the selective activation of a subset of a dense pattern of ablation elements. Embodiments of the device include an ablational electrode array that spans 360 degrees and an array that spans an arc of less than 360 degrees.
    Type: Grant
    Filed: May 2, 2008
    Date of Patent: February 4, 2014
    Assignee: Covidien LP
    Inventors: Douglas Kelly, David S. Utley, Robert A. Ganz, Michael P. Wallace, Nathan Every
  • Patent number: 8442645
    Abstract: A lower esophageal sphincter tightening device for treating gastroesophageal reflux disease which includes an insertion device, an energy source, and an energy transmitting device. The insertion device, by insertion through a body opening, positions the energy transmitting device in the proximity of the lower esophageal sphincter. The energy source generates and transmits energy via the insertion device to the energy transmitting device which directs the transmitted energy onto the lower esophageal sphincter which is comprised largely of collagen. The energy source transmits energy at a level sufficient to cause heating of the sphincter's collagen resulting in a shrinkage of the collagen and a tightening of the sphincter.
    Type: Grant
    Filed: March 24, 2011
    Date of Patent: May 14, 2013
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Brian D. Zelickson, Robert A. Ganz